Lisata Therapeutics, Inc. (LSTA)Healthcare | Biotechnology | Basking Ridge, United States | NasdaqCM
1.02 USD
-0.06
(-5.556%) ⇩
(Oct. 14, 2026, 4 p.m.
EDT)
After hours: 1.02 |
Hot Take ↕ | Oct. 10, 2026, 9:57 a.m. EDT
The immediate outlook is severely compromised by a pending acquisition that has failed to secure necessary financing, causing the stock to plummet from the $4 tender offer price to current levels near $1. While the recent price action shows a brief, volatile spike before collapsing, the lack of a definitive deal leaves the company in a precarious limbo with no clear path to value realization. Looking further ahead, the business fundamentals are catastrophic; the company has endured a brutal decade-long decline, losing over 96% of its value since 2016, and currently burns massive amounts of cash with no revenue to speak of. The balance sheet is deteriorating under the weight of these losses, and the market has correctly priced this as a failing enterprise rather than a speculative opportunity. There is no dividend to provide any cushion, making this a high-risk situation where capital is likely to be eroded until a buyer emerges or the company runs out of runway. |
| Model | MAE |
|---|---|
| AutoETS ✓ | 0.293189 |
| AutoTheta | 0.898889 |
| AutoARIMA | 0.909266 |
| MSTL | 1.048729 |
Forecast horizon: 45 days | Selected: AutoETS
| Forecast Reliability | |
|---|---|
| Score | 33% |
| H-stat | 0.97 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.170 |
| Excess Kurtosis | -1.20 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Revenue per Share | 0.011 |
| Market Cap | 11,020,147 |
| Forward P/E | -0.88 |
| Beta | 0.95 |
| Previous Name | Caladrius Biosciences, Inc. |
| Website | https://www.lisata.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.5555556 |
| Address1 | 110 Allen Road |
| Address2 | 2nd Floor |
| All Time High | 637,500.0 |
| All Time Low | 0.98 |
| Ask | 1.26 |
| Ask Size | 1 |
| Average Daily Volume10 Day | 161,080 |
| Average Daily Volume3 Month | 308,040 |
| Average Volume | 308,040 |
| Average Volume10Days | 161,080 |
| Beta | 0.945 |
| Bid | 1.17 |
| Bid Size | 1 |
| Book Value | 0.904 |
| City | Basking Ridge |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 1.02 |
| Current Ratio | 3.687 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,790,726,400 |
| Day High | 1.05 |
| Day Low | 0.996 |
| Display Name | Lisata Therapeutics |
| Dividend Yield | 0.0 |
| Earnings Call Timestamp End | 1,762,464,600 |
| Earnings Call Timestamp Start | 1,762,464,600 |
| Earnings Timestamp End | 1,793,908,800 |
| Earnings Timestamp Start | 1,793,908,800 |
| Ebitda | -16,362,000 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | 0.092 |
| Enterprise To Revenue | -15.058 |
| Enterprise Value | -1,505,844 |
| Eps Current Year | -1.09 |
| Eps Forward | -1.16 |
| Eps Trailing Twelve Months | -1.64 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 15 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 1.417 |
| Fifty Day Average Change | -0.39700007 |
| Fifty Day Average Change Percent | -0.28016943 |
| Fifty Two Week Change Percent | -55.555557 |
| Fifty Two Week High | 5.07 |
| Fifty Two Week High Change | -4.05 |
| Fifty Two Week High Change Percent | -0.79881656 |
| Fifty Two Week Low | 0.98 |
| Fifty Two Week Low Change | 0.03999996 |
| Fifty Two Week Low Change Percent | 0.04081629 |
| Fifty Two Week Range | 0.98 - 5.07 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 920,298,600,000 |
| Float Shares | 6,758,924 |
| Forward Eps | -1.16 |
| Forward P E | -0.87931037 |
| Free Cashflow | -8,100,250 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 21 |
| Fullday Change | -0.060000062 |
| Fullday Change Percent | -5.555561 |
| Fullday Price | 1.02 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 1.0 |
| Gross Profits | 100,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.2226 |
| Held Percent Institutions | 0.11123 |
| Implied Shares Outstanding | 10,804,066 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,663,200,000 |
| Last Split Factor | 1:15 |
| Long Business Summary | Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product is certepetide, which is in Phase 2 clinical studies for the treatment of solid tumors, such as metastatic pancreatic ductal adenocarcinoma, cholangiocarcinoma, appendiceal cancer, and colon cancer and glioblastoma multiforme in combination with range of anti-cancer regimens. Lisata Therapeutics, Inc. was formerly known as Caladrius Biosciences, Inc. and changed its name to Lisata Therapeutics, Inc. in September 2022. The company was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey. |
| Long Name | Lisata Therapeutics, Inc. |
| Market | us_market |
| Market Cap | 11,020,147 |
| Market State | POSTPOST |
| Max Age | 86,400 |
| Message Board Id | finmb_338272 |
| Most Recent Quarter | 1,782,777,600 |
| Name Change Date | 2,026-10-14 |
| Net Income To Common | -14,621,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 15,990,017 |
| Open | 1.0 |
| Operating Cashflow | -12,323,000 |
| Operating Margins | -164.26 |
| Peg Ratio | 118.4 |
| Phone | 908 842 0100 |
| Post Market Change | 0.0 |
| Post Market Change Percent | 0.0 |
| Post Market Price | 1.02 |
| Post Market Time | 1,792,015,923 |
| Prev Name | Caladrius Biosciences, Inc. |
| Previous Close | 1.08 |
| Price Eps Current Year | -0.93577975 |
| Price Hint | 4 |
| Price To Book | 1.1283185 |
| Price To Sales Trailing12 Months | 110.20147 |
| Profit Margins | 0.0 |
| Quick Ratio | 3.563 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.0600001 |
| Regular Market Change Percent | -5.55556 |
| Regular Market Day High | 1.05 |
| Regular Market Day Low | 0.996 |
| Regular Market Day Range | 0.996 - 1.05 |
| Regular Market Open | 1.0 |
| Regular Market Previous Close | 1.08 |
| Regular Market Price | 1.02 |
| Regular Market Time | 1,792,008,001 |
| Regular Market Volume | 80,237 |
| Return On Assets | -0.56740004 |
| Return On Equity | -1.01658 |
| Revenue Per Share | 0.011 |
| Sand P52 Week Change | 0.17004645 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 10,804,066 |
| Shares Percent Shares Out | 0.0036000002 |
| Shares Short | 39,407 |
| Shares Short Previous Month Date | 1,788,134,400 |
| Shares Short Prior Month | 141,798 |
| Short Name | Lisata Therapeutics, Inc. |
| Short Percent Of Float | 0.0043 |
| Short Ratio | 0.14 |
| Source Interval | 15 |
| State | NJ |
| Symbol | LSTA |
| Total Cash | 10,443,000 |
| Total Cash Per Share | 1.159 |
| Total Debt | 0 |
| Total Revenue | 100,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -1.64 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 3.05435 |
| Two Hundred Day Average Change | -2.03435 |
| Two Hundred Day Average Change Percent | -0.6660501 |
| Type Disp | Equity |
| Volume | 80,237 |
| Website | https://www.lisata.com |
| Zip | 7,920 |